Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pablo I. Sánchez-Aguilera"'
Autor:
Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Belend Mahmoud, Albert Gerding, Justina C. Wolters, Anouk H. G. Wolters, Ben N. G. Giepmans, Herman H. W. Silljé, Rudolf A. de Boer, Barbara M. Bakker, B. Daan Westenbrink
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract A Kinase Interacting Protein 1 (AKIP1) is a signalling adaptor that promotes mitochondrial respiration and attenuates mitochondrial oxidative stress in cultured cardiomyocytes. We sought to determine whether AKIP1 influences mitochondrial fu
Externí odkaz:
https://doaj.org/article/0f6febf0dad84f44a4fe25e6b176abbe
Autor:
Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, B. Daan Westenbrink
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract A Kinase Interacting Protein 1 (AKIP1) is a signalling adaptor that promotes physiological hypertrophy in vitro. The purpose of this study is to determine if AKIP1 promotes physiological cardiomyocyte hypertrophy in vivo. Therefore, adult ma
Externí odkaz:
https://doaj.org/article/ed562cee66ed427ca8cecb89312bca87
Autor:
Kirsten T. Nijholt, Pablo I. Sánchez‐Aguilera, Suzanne N. Voorrips, Rudolf A. de Boer, B. Daan Westenbrink
Publikováno v:
European Journal of Heart Failure. 24(2):287-298
Impaired exercise capacity is the key symptom of heart failure (HF) and is associated with reduced quality of life and higher mortality rates. Unfortunately, current therapies, although generally lifesaving, have only small or marginal effects on exe
Publikováno v:
Current Opinion in Physiology. 33:100656
Autor:
Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Publikováno v:
International Journal of Molecular Sciences, 23(15):8631. MDPI AG
Despite the constant improvement of therapeutical options, heart failure (HF) remains associated with high mortality and morbidity. While new developments in guideline-recommended therapies can prolong survival and postpone HF hospitalizations, impai
Autor:
Harmen G Booij, Mario G. Pavez-Giani, Salva R. Yurista, B. Daan Westenbrink, Silke U. Oberdorf-Maass, Joan Heller Brown, Nils Bomer, Hendrik Milting, Shigeki Miyamoto, Rudolf A. de Boer, Peter van der Meer, Herman W H Sillje, Paula Giraldo, Pablo I Sánchez-Aguilera, Kirsten T Nijholt
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4427, p 4427 (2021)
International Journal of Molecular Sciences, 22(9), 1-20. MDPI AG
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4427, p 4427 (2021)
International Journal of Molecular Sciences, 22(9), 1-20. MDPI AG
ATPase inhibitory factor-1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunction and pathol
Autor:
Pablo I Sánchez-Aguilera, Salva R. Yurista, Rudolf A. de Boer, Silke Oberdorf-Maass, Joan Heller Brown, B. Daan Westenbrink, Paula Giraldo, Hendrik Milting, Shigeki Miyamoto, Nils Bomer, Kirsten T Nijholt, Herman H W Silljé, Peter van der Meer, Mario G. Pavez-Giani
Background : ATPase inhibitor factor-1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunctio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b568457dac326c97decc678dd3cc6794